Cogent Biosciences COGT
NASDAQ COGT
$31.43 +0.19 (+0.61%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) Revenue (2017 - 2020)

Updated

Cogent Biosciences' Revenue was $7.87 million in FY2020, down 65.0% from $22.5 million in FY2019.

Analysis

Cogent Biosciences (COGT) Revenue (2017 - 2020) Analysis & Trends

From FY2017 onward, Cogent Biosciences has reported Revenue for 4 years.

  • Revenue shows a three-year compound annual growth rate of -2.0% (FY2017 to FY2020).
  • Per Business Quant data, Revenue in earlier years was $22.5 million in FY2019 (+131.1%), $9.73 million in FY2018 (+16.4%) and $8.36 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.31 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 16.99 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 15.03 Bn
10 Cogent Biosciences 5.38 Bn 2.43 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 312,000.00
Jun 30, 2020 528,000.00
Mar 31, 2020 7.03 Mn
Dec 31, 2019 15.29 Mn
Sep 30, 2019 1.02 Mn
Jun 30, 2019 3.14 Mn
Mar 31, 2019 3.05 Mn
Dec 31, 2018 3.81 Mn
Sep 30, 2018 2.04 Mn
Jun 30, 2018 1.67 Mn
Mar 31, 2018 2.22 Mn
Dec 31, 2017 2.12 Mn
Sep 30, 2017 2.33 Mn
Jun 30, 2017 2.08 Mn
Mar 31, 2017 1.83 Mn
API Access

Cogent Biosciences Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=COGT&period=max&api_key=YOUR_API_KEY